ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,385,041, issued on Aug. 12, was assigned to City of Hope (Duarte, Calif.), California Institute of Technology (Pasadena, Calif.) and The General Hospital Corp. (Boston).
"Conditional-siRNAS and uses thereof in treating cardiac hypertrophy" was invented by Saumya Das (Boston), Ane Miren Salvador Garicano (Boston), Si-ping Han (Duarte, Calif.), Lisa Scherer (Duarte, Calif.), Julia Derogatis (Duarte, Calif.), Robin Hu (Duarte, Calif.), Sahil Sagar (Duarte, Calif.), William A. Goddard III (Pasadena, Calif.) and John Rossi (Duarte, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are conditional siRNAs activatable by pro-hypertrophic RN...